About Acpharis
Acpharis is a Healthcare company based in Holliston (United States) founded in 2008. Protein-based technologies are developed for early-stage drug discovery acceleration. Its Indian entity Ironsource India Private Limited reported revenue of ₹21.75 Cr. Acpharis offers products and services including Computational Solvent Mapping, Protein-Protein Docking, and Customized Services. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its competitors include NantHealth, BioAge Labs and Perthera; 3 of its 3 listed competitors have raised funding.
Company details
Acpharis is focussed on providing early-stage drug discovery services which include homology modeling of proteins, high throughput virtual screening of databases, and the assessment of compounds in libraries. It has developed two technologies namely Piper which elucidates the details of specific protein interactions at the atomic level and Atlas which is used for the computational mapping of proteins using organic solvents as probes. It has received an SBIR grant to produce software for modeling and optimization of protein therapeutics.
- Headquarters Holliston, United States
- SectorsHealthcare
- Email••••••••
- Website acpharis.com
- Social LinkedIn X
- Legal Name Ironsource India Private Limited
- Date of Incorporation 26 Apr, 2016
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹21.75 Cr
FY 2025 · +206% YoY
- Indian entity net profit₹3.79 Cr
FY 2025 · 17% margin
- Indian entity EBITDA₹5.88 Cr
FY 2025 · 27% margin
- Latest Funding Round$202.27K (USD), Grant
Sep 2024
- Investors
Associated legal entities of Acpharis
Acpharis operates through Ironsource India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ironsource India Private Limited CIN U74300KA2016FTC092539 | Active | 26 Apr 2016 | Bangalore, Karnataka | ₹21.7 Cr | 21 | 4 | View details |
Products & Services of Acpharis
Acpharis offers a comprehensive portfolio of products and services, including Computational Solvent Mapping, Protein-Protein Docking, and Customized Services.
Tool to identify druggable binding sites for early-stage drug discovery.
Software for modeling protein interactions in research applications.
Tailored modeling services for drug discovery needs.
Funding Insights of Acpharis
- Total Rounds 9
- Last Round Grant — $202,274
- First Round $98,055
(May 2011)
- Investors Count 1
All 9 funding rounds of Acpharis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Acpharis
Acpharis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Acpharis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ironsource India Private Limited (Acpharis)
Ironsource India Private Limited is the primary company behind Acpharis. The board of Ironsource India Private Limited currently have 4 directors; the longest-serving is Nora Sen Go, appointed in 2024. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nora Sen Go DIN 10531941 | Director | 04 Mar 2024 | 2 yrs 8 mo | Ironsource India Private Limited |
| Bhagavant Bedi DIN 08005696 | Director | 21 Nov 2024 | 1 yr 11 mo | Ironsource India Private Limited |
| Jasmine De Layton DIN 10792925 | Director | 08 Jul 2025 | 1 yr 4 mo | Ironsource India Private Limited |
| Shridhar Subbaraman Iyer DIN 07151577 | Director | 30 Oct 2025 | 1 yr | Ironsource India Private Limited |
Financials of Acpharis
Figures of Ironsource India Private Limited, the primary company behind Acpharis, for FY 2025. Revenue was ₹21.75 Cr (+206% year on year). Net profit was ₹3.79 Cr (17% margin). EBITDA was ₹5.88 Cr (27% margin). Revenue has grown at a compounded annual rate of +87% over three years and +59% over five years.
- ₹21.75 CrRevenue · FY 2025 · +206% YoY
- ₹3.79 CrNet profit · 17% margin
- ₹5.88 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- 21Employees (provident fund records)
- +87%Revenue CAGR, 3 years
- +59%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ironsource India Private Limited are on its company page.
Detailed financial statements for Acpharis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Acpharis
3 dated milestones of Acpharis across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Acpharis is founded.
- Funding First funding round of $98K.
- Funding Latest funding round, Grant, of $202K.
Competitors of Acpharis
Acpharis has 3 listed competitors in our database, 3 of them funded. They include NantHealth, BioAge Labs and Perthera.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanthealth.com | 2007 | El Segundo, United States | $607.58M | 380 | Bioinformatics platforms are provided for cancer treatment identification. | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. | |
| perthera.com | 2012 | Mclean, United States | $17.02M | 13 | Molecular cancer profiling is conducted via genomics and proteomics. |
Detailed competitors of Acpharis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Acpharis (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Acpharis
Complete news archive for Acpharis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acpharis
Acpharis was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Acpharis is headquartered in Holliston, United States. It is registered at Holliston, Massachusetts, United States.
The primary company behind Acpharis, Ironsource India Private Limited, reported revenue of ₹21.75 Cr for FY 2025, up 206% year on year.
Acpharis is focussed on providing early-stage drug discovery services which include homology modeling of proteins, high throughput virtual screening of databases, and the assessment of compounds in libraries. It has developed two technologies namely Piper which elucidates the details of specific protein interactions at the atomic level and Atlas which is used for the computational mapping of proteins using organic solvents as probes. It has received an SBIR grant to produce software for modeling and optimization of protein therapeutics.
Acpharis's top competitors include NantHealth, BioAge Labs and Perthera.
Acpharis offers Computational Solvent Mapping, Protein-Protein Docking, and Customized Services.
Acpharis has 1 investor. Key investors include HHS.
Acpharis operates through Ironsource India Private Limited.
The legal entities of Acpharis currently have 4 directors, including Nora Sen Go, Bhagavant Bedi, Shridhar Subbaraman Iyer and others.